Physician profile
Stephen Humphrey
NPI 1154379428
$62,601.38
in general payments reported to CMS, 2019-2025
8 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,705 · 2020: $9,623 · 2021: $9,639 · 2023: $7,964 · 2024: $15K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $33K · Food and Beverage: $677 · Travel and Lodging: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $32,613.35 |
| Food and Beverage | $677.11 |
| Travel and Lodging | $343.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $61,429.97 | 2019-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Nevro Corp. | $489.76 | 2024 | Senza |
| Medtronic, INC. | $364.10 | 2021-2025 | Venaseal, Intellis Adaptivestim, Inceptiv |
| Globus Medical, INC. | $146.05 | 2025 | Senza |
| Medtronic Vascular, INC. | $83.68 | 2019-2020 | |
| Tactile Systems Technology INC | $44.49 | 2019 | |
| Becton, Dickinson and Company | $22.99 | 2024 | Powerport M.R.I. Implantable Port |
| Pacira Pharmaceuticals Incorporated | $20.34 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Humphrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.